The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies

Benzer Materyaller

• Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
  Yazar:: De Rycke, L, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Induction of ANA, anti-dsDNA and anti-nucleosome antibodies following infliximab treatment in rheumatoid arthritis and spondyloarthropathy patients
  Yazar:: de Rycke, LEB, ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• Changes in rheumatoid factor reflect the inflammatory response (CRP and ESR) to infliximab treatment
  Yazar:: De Rycke, L, ve diğerleri
  Baskı/Yayın Bilgisi: (2003)
• False positivity of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
  Yazar:: Hoffman, IEA, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Sensitivity of ANA indirect immunofluorescence testing for the detection of anti-ENA antibodies
  Yazar:: Hoffman, IEA, ve diğerleri
  Baskı/Yayın Bilgisi: (2002)